{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:14:03Z","timestamp":1785795243220,"version":"3.56.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Opioid exposure during pregnancy has been associated with preterm birth, but prior studies have not differentiated between spontaneous and indicated preterm birth or fully investigated these associations as functions of opioid dose.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether prescription opioid use during pregnancy is associated with spontaneous preterm birth and whether the association is dose-dependent.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This case-control study examined a retrospective cohort of pregnant patients enrolled in Tennessee Medicaid. Enrollment files were linked to health care encounters, hospital discharge information, birth certificate data, and prescription fills. Eligible participants were pregnant people ages 15 to 44 years without opioid use disorder who experienced birth of a single fetus at 24 weeks gestation or greater between 2007 and 2019 with linked birth certificate data. Cases of spontaneous preterm birth were matched with up to 10 controls based on pregnancy start date, race, ethnicity, age at delivery within 2 years, and history of prior preterm birth. Cases and matched controls were continuously enrolled in TennCare for at least 90 days prior to the index date (case delivery date).<\/jats:p><\/jats:sec>Exposure<\/jats:title>Total opioid MME filled during the 60 days prior to the index date.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was spontaneous preterm birth determined by a validated algorithm using birth certificate data. Conditional logistic regression was used to estimate the association between spontaneous preterm birth and total opioid morphine milligram equivalents (MME) dispensed, adjusting for parity, prepregnancy body mass index, education level, tobacco use, hepatitis infections, and pain indications.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 25\u202f391 cases (median [IQR] age, 23 [20-28] years; 127 Asian [0.5%], 9820 Black [38.7%], 664 Hispanic [2.6%]; 14\u202f748 non-Hispanic White [58.1%]) with spontaneous preterm birth were identified and matched with 225\u202f696 controls (median [IQR] age, 23 [20-27] years; 229 Asian [0.1%], 89\u202f819 Black [39.8%], 3590 Hispanic [1.6%]; 132\u202f002 non-Hispanic White [58.5%]) (251\u202f087 patients total), with 18\u202f702 patients (7.4%) filling an opioid prescription in the 60 days prior to the index date. Each doubling of nonzero opioid MME was associated with a 4% increase in the odds of spontaneous preterm birth compared with no opioid exposure (adjusted odds ratio, 1.04; 95% CI, 1.01-1.08).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this case-control study, a positive association was found between total prescription opioid dose dispensed and the odds of spontaneous preterm birth. These findings support guidance to minimize opioid exposure during pregnancy and prescribe the lowest dose necessary.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.55990","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:01:18Z","timestamp":1707926478000},"page":"e2355990","source":"Crossref","is-referenced-by-count":14,"title":["Prescription Opioid Exposure During Pregnancy and Risk of Spontaneous Preterm Delivery"],"prefix":"10.1001","volume":"7","author":[{"given":"Olivia M.","family":"Bosworth","sequence":"first","affiliation":[{"name":"Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Padilla-Azain","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Adgent","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Spieker","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew David","family":"Wiese","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Leech","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Osmundson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"issue":"3","key":"zoi231645r1","doi-asserted-by":"publisher","first-page":"275.e1","DOI":"10.1016\/j.ajog.2018.06.002","article-title":"Use of nonsteroidal anti-inflammatory drugs during pregnancy and the risk of miscarriage.","volume":"219","author":"Li","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi231645r3","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion No. 711: opioid use and opioid use disorder in pregnancy.","volume":"130","author":"American College of Obstetricians and Gynecologists","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi231645r4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among Medicaid-enrolled women.","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi231645r5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/EDE.0000000000001328","article-title":"Prenatal opioid analgesics and the risk of adverse birth outcomes.","volume":"32","author":"Brogly","year":"2021","journal-title":"Epidemiology"},{"issue":"8","key":"zoi231645r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28588","article-title":"Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns.","volume":"5","author":"Esposito","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi231645r7","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/AOG.0000000000004479","article-title":"Prediction and prevention of spontaneous preterm birth: ACOG practice bulletin, number 234.","volume":"138","author":"American College of Obstetricians and Gynecologists","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi231645r8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5055\/jom.2021.0632","article-title":"Prescription opioid use during pregnancy and risk for preterm birth or term low birthweight.","volume":"17","author":"Interrante","year":"2021","journal-title":"J Opioid Manag"},{"issue":"12","key":"zoi231645r9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study.","volume":"16","author":"Sujan","year":"2019","journal-title":"PLoS Med"},{"issue":"1","key":"zoi231645r10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ppe.v36.1","article-title":"Infants\u2019 prenatal exposure to opioids and the association with birth outcomes: a systematic review and meta-analysis.","volume":"36","author":"Graeve","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1","key":"zoi231645r11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/epirev\/mxaa007","article-title":"Prescription opioid use among populations of reproductive age: effects on fertility, pregnancy loss, and pregnancy complications.","volume":"42","author":"Flannagan","year":"2020","journal-title":"Epidemiol Rev"},{"issue":"6","key":"zoi231645r12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7326\/M17-1907","article-title":"Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study.","volume":"168","author":"Wiese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi231645r14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/ppe.2016.30.issue-2","article-title":"Development and validation of an algorithm to determine spontaneous versus provider-initiated preterm birth in US vital records.","volume":"30","author":"Klebanoff","year":"2016","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"zoi231645r15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-0037-1608804","article-title":"Neonatal outcomes differ after spontaneous and indicated preterm birth.","volume":"35","author":"Stout","year":"2018","journal-title":"Am J Perinatol"},{"issue":"3","key":"zoi231645r16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/ppe.2017.31.issue-3","article-title":"Accuracy of birth certificate data for classifying preterm birth.","volume":"31","author":"Stout","year":"2017","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5 Pt 1","key":"zoi231645r17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/01.AOG.0000158124.96300.c7","article-title":"Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000.","volume":"105","author":"Ananth","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi231645r18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/AOG.0b013e318184181a","article-title":"Estimating recurrence of spontaneous preterm delivery.","volume":"112","author":"Esplin","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi231645r19","first-page":"1","article-title":"Births: final data for 2021.","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Syst"},{"issue":"3","key":"zoi231645r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"zoi231645r21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/aje\/kww122","article-title":"Modeling variables with a spike at zero: examples and practical recommendations.","volume":"185","author":"Lorenz","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"7","key":"zoi231645r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8256","article-title":"Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018.","volume":"3","author":"Corsi","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi231645r23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s40264-021-01115-6","article-title":"Maternal complications and prescription opioid exposure during pregnancy: using marginal structural models.","volume":"44","author":"Wen","year":"2021","journal-title":"Drug Saf"},{"issue":"11","key":"zoi231645r24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/jgs.1991.39.issue-11","article-title":"Comparing sources of drug data about the elderly.","volume":"39","author":"Johnson","year":"1991","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi231645r25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/oxfordjournals.aje.a115198","article-title":"Use of Medicaid data for pharmacoepidemiology.","volume":"129","author":"Ray","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi231645r26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jama.2018.6971","article-title":"Odds ratios\u2014current best practice and use.","volume":"320","author":"Norton","year":"2018","journal-title":"JAMA"},{"key":"zoi231645r2","unstructured":"US Food and Drug Administration. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication\u2014Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later. Last updated October 15, 2020. Accessed June 13, 2023. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/nonsteroidal-anti-inflammatory-drugs-nsaids-drug-safety-communication-avoid-use-nsaids-pregnancy-20"},{"key":"zoi231645r13","unstructured":"Division of TennCare. TennCare Overview. Accessed June 13, 2023. https:\/\/www.tn.gov\/tenncare\/information-statistics\/tenncare-overview.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815071\/bosworth_2024_oi_231645_1707335329.47719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:01:22Z","timestamp":1707926482000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.55990","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}